Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New canine DNA tests released
“Now, there is no reason for any more border terriers to be born with shaking puppy syndrome, illustrating the enormous potential of DNA testing."
AHT launches tests for three breeds

The Animal Health Trust (AHT) has released three new DNA tests for Lhasa apsos, border terriers and northern Inuit dogs.

A long-awaited DNA test for progressive retinal atrophy (PRA4) in Lhasa apsos was launched in September. In the UK Lhasa population, a significant 15 per cent are thought to be carriers for this mutation. As a result, one in 145 dogs is likely to be affected by this type of PRA, which causes degenerative blindness.

Secondly, the AHT collaborated with the University of Missouri and Wisdom Health to investigate ‘shaking puppy syndrome’ in border terriers. Puppies affected by this devastating neurological disease (spongiform leucoencephalomyelopathy) show severe tremors as soon as they begin to walk. Most die at a young age or are euthanised on welfare grounds.

AHT says the disease is a simple recessive trait and therefore could be controlled through prompt and robust DNA testing. The AHT DNA Testing Service is the first to be able to offer the test in the UK and Europe. Further research is ongoing and will be published in a peer-reviewed journal upon completion.

Dr Cathryn Mellersh, head of canine genetics at AHT, said: “It can be very difficult to identify the gene linked to an emerging neurological disease such as this, but the result is fantastic and we are very pleased to be able to quickly offer the DNA test for the UK and European market.

“Now, there is no reason for any more border terriers to be born with shaking puppy syndrome, illustrating the enormous potential of DNA testing when implemented quickly and effectively across a breed.”

The third test is for oculoskeletal dysplasia (OSD) in northern Inuits. Affected dogs show various skeletal malformations such as dwarfism and blindness at an early age. It has been named OSD3 because, although it is similar to OSD in Labradors and Samoyeds, it is genetically different. The mutation was discovered by a team of AHT ophthalmologists and geneticists. Now, northern Inuits, utonagans, tamaskan dogs and other wolf-like breeds can be tested for the mutation at the AHT.

Commenting on the new tests Dr Mellersh added: “Our team have been working really hard on these projects and a lot of work has gone on behind the scenes to bring these new tests to the market promptly after the mutations were discovered.
 
“The research has been spurred on by very engaged and proactive breeders who have been fantastic in helping us collect DNA samples from enough dogs to base the research upon.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.